No Picture
News

Biotech Briefing: BioTime Changes Name and Moves to Carlsbad

Reports + Research BioTime Changes Name and Moves to Carlsbad BioTime changed its name to Lineage Cell Therapeutics (NYSE: LCTX) and is relocating its corporate headquarters to Carlsbad in mid-August. Lineage Cell Therapeutics develops cell therapies f… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Finding a cause of neurodevelopmental disorders

LA JOLLA?Neurodevelopmental disorders arising from rare genetic mutations can cause atypical cognitive function, intellectual disability, and developmental delays, yet it is unclear why and how this happens.?Scientists suspected a mutation in a complex… […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

As cancer detection companies thrive, Exact Sciences looks to consolidate by spending $2.8B to acquire peer Genomic Health

As predicted by Bloomberg, cancer diagnostics company Exact Sciences is buying peer Genomic Health in a?$2.8 billion cash-and-stock deal.?
Exact Sciences? flagship colorectal cancer test Cologuard will complement Genomic Health?s Oncotype DX, a test de… […]

No Picture
News

Two therapeutic targets identified for deadly lung cancer

LA JOLLA?(July 26, 2019) The vast majority of deadly lung cancer cases (85 percent) are termed non-small-cell lung carcinomas (NSCLCs), which often contain a mutated gene called LKB1. Salk Institute researchers have now discovered precisely why inactiv… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

INmune Bio Co-Founder and CEO Presents at 17th Annual Congress of International Drug Discovery Science & Technology 2019

LA JOLLA, Calif., July 25, 2019 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient?s innate immune system to fight disease, today announced that C.J. Barnum, Director o… […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Obalon Announces Second Quarter 2019 Financial Results

SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obe… […]

No Picture
News

Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for Lead Immuno-oncology Product Candidate, THOR-707

SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) — Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, announced today it has opened HAMMER, a global, Phase 1/2, first… […]

No Picture
News

Digestion-aiding herbs alter gut microbiome

Many medicines used today?including aspirin, penicillin and malaria-fighting quinine?originated from nature. Now, Sanford Burnham Prebys and UC San Diego scientists have turned to ancient digestive herbs to learn about gut health?in the hopes of uncove… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Unlocking therapies for hard-to-treat lung cancers

LA JOLLA?Around 85 percent of lung cancers are classified as non-small-cell lung cancers, or NSCLCs. Some patients with these cancers can be treated with targeted genetic therapies, and some benefit from immunotherapies?but the vast majority of NSCLC p… […]

No Picture
News

As Takeda absorbs Shire’s R&D ops, the focus is on replacing a centralized command model with a ‘light touch’ in a restructured global organization

At Takeda, one of the top priorities in the R&D group since the $62 billion acquisition of Shire closed at the beginning of the year has been centered on creating a shared culture ? and that calls for some group activities.?
Six weeks after the dea… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Aptose To Release Second Quarter Ended June 30, 2019 Financial Results and Hold Conference Call on August 6, 2019

SAN DIEGO and TORONTO, July 23, 2019 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes and signaling pathways of cancer… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

GenMark Diagnostics Schedules Second Quarter 2019 Financial Results Conference Call for August 5, 2019

CARLSBAD, Calif., July 22, 2019 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close on?Monday, August 5, 2019. Management will hold a conference … […]

No Picture
News

Obalon Schedules Second Quarter 2019 Financial Results Conference Call for July 24, 2019 at 8:30 a.m. Eastern Time

SAN DIEGO, July 22, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of ob… […]